Source link : https://www.newshealth.biz/health-news/year-in-review-chronic-lymphocytic-leukemia/
Developments in chronic lymphocytic leukemia (CLL) this year included the first CAR T-cell therapy approval for the chronic blood cancer, potential treatments for Richter transformation, and investigations into triplet regimens. First CAR-T Approved for CLL In March, the FDA granted accelerated approval to lisocabtagene maraleucel (liso-cel, Breyanzi) for pretreated CLL or small lymphocytic lymphoma (SLL). […]
Author : News Health
Publish date : 2024-12-10 17:02:10
Copyright for syndicated content belongs to the linked Source.
inHealth